PHARBETOL

Generic: ACETAMINOPHEN

Manufacturer: Allegiant Health

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Benzodiazepine [EPC]Proton Pump Inhibitor [EPC]Vitamin C [EPC]
239,588
Total Reports
147,234
Serious Reports
46,918
Death Reports
30
Reported Reactions
Death Report Ratio: High (19.58%)

Patient Demographics

Male
78,986
Female
130,887

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for PHARBETOL.

# Reaction Reports % of Total
1 OFF LABEL USE 21,662
6.0%
2 FATIGUE 19,933
5.5%
3 DRUG INEFFECTIVE 17,781
4.9%
4 PAIN 17,737
4.9%
5 NAUSEA 17,144
4.8%
6 HEADACHE 16,296
4.5%
7 TOXICITY TO VARIOUS AGENTS 14,611
4.1%
8 DYSPNOEA 14,191
3.9%
9 ARTHRALGIA 14,076
3.9%
10 PYREXIA 13,953
3.9%
11 VOMITING 13,616
3.8%
12 DIARRHOEA 13,041
3.6%
13 RASH 12,170
3.4%
14 INFUSION RELATED REACTION 10,805
3.0%
15 PNEUMONIA 10,706
3.0%
16 MALAISE 9,980
2.8%
17 CONDITION AGGRAVATED 9,503
2.6%
18 DIZZINESS 9,384
2.6%
19 ASTHENIA 9,363
2.6%
20 PRURITUS 9,289
2.6%
21 NASOPHARYNGITIS 8,947
2.5%
22 DEATH 8,943
2.5%
23 JOINT SWELLING 8,784
2.4%
24 RHEUMATOID ARTHRITIS 8,704
2.4%
25 WEIGHT INCREASED 8,449
2.3%
26 SINUSITIS 8,284
2.3%
27 HYPERTENSION 8,212
2.3%
28 FALL 8,195
2.3%
29 HYPERSENSITIVITY 8,054
2.2%
30 COMPLETED SUICIDE 7,992
2.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.